Fredrik Dahl
Fortuna: 444 692 $ al 31/05/2026
Fortuna: 444 692 $ al 31/05/2026
Fredrik Dahl is the founder of Colibri Ventures AB,Pixelgen Technologies AB. Currently, Dr. Dahl is Chairman at Faboss Invest AB, Director at Devyser Diagnostics AB starting 2025, Director at Nucleus Capital AB, and Director at Llya Pharma AB. Formerly, Dr. Dahl was Director at Moligo Technologies AB, Chief Technology Officer at Halo Genomics AB, and Chief Technology Officer at Vanadis Diagnostics AB. Education includes undergraduate and doctorate degrees from the University of Uppsala.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DEVYSER DIAGNOSTICS AB 0,27 % | 07/05/2025 | 44.150 ( 0,27 % ) | 444 692 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Director/Miembro de la Junta | 01/01/2021 |
Colibri Ventures AB | Fundador | - |
Faboss Invest AB | Presidente | - |
Nucleus Capital AB | Director/Miembro de la Junta | - |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Fundador | - |
Llya Pharma AB | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Director Técnico/Científico/I+D | - |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Director Técnico/Científico/I+D | - |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Health Services |
Devyser Diagnostics AB
Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Commercial Services |
Colibri Ventures AB | |
Faboss Invest AB | |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Health Technology |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Technology Services |
Nucleus Capital AB | |
Llya Pharma AB |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.